Codexis Inc. (CDXS) |
|
12.95 -0.56 (-4.15%)
|
02-25 16:00 |
|
Open: |
13.55 |
Pre. Close: |
13.51 |
|
High:
|
13.59 |
Low:
|
12.89 |
|
Volume:
|
313,306 |
Market Cap:
|
758M |
|
|
|
|
Codexis Inc is a biotech company. It develops proprietary biocatalysts-enzymes or microbes that initiate or accelerate chemical reactions. It offers its products to the pharmaceutical industry. The company also develops advanced biofuels. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
13.605 - 13.716 |
13.716 - 13.79 |
|
Low:
|
12.667 - 12.785 |
12.785 - 12.865 |
|
Close:
|
12.795 - 12.978 |
12.978 - 13.102 |
|
Technical analysis |
as of: 2020-02-25 4:28:04 PM |
|
Overall:
|
  |
| Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected. |
| Target: |
Six months: 18.74 One year: 21.02 |
| Support: |
Support1: 12.89 Support2: 10.72 |
| Resistance: |
Resistance1: 16.05 Resistance2: 18.00 |
| Pivot: |
14.66 |
| Moving Average: |
MA(5): 13.70 MA(20): 15.01
MA(100): 15.31 MA(250): 16.86 |
| MACD: |
MACD(12,26): -0.85 Signal(9): -0.67 |
| Stochastic oscillator: |
%K(14,3): 6.39 %D(3): 7.06  |
| RSI: |
RSI(14): 19.50 |
| 52-week: |
High: 22.38 Low: 12.68 Change(%): -40.4 |
| Average Vol(K): |
3-Month: 33948 10-Days: 45603 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.CDXS has closed above bottom band by 10.1%. Bollinger Bands are 100.5% wider than normal. The large width of the bands suggest high volatility as compared to CDXS's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue. |
|
|
Headline News |
2019-11-12
Codexis, Inc. (NASDAQ:CDXS) Expected to Post Quarterly Sales of $22.82 Million
Equities analysts forecast that Codexis, Inc. (NASDAQ:CDXS) will post $22.82 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for Codexis’ earnings, with estimates ranging from $20.70 million to $24.93 million. Codexis posted sales of $16.07 million during the same quarter last year, which would indicate a […]
2019-11-06
Codexis (CDXS) Upgraded to Buy: What Does It Mean for the Stock?
Codexis (CDXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
|
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
